Company news: Althea; Cann Group; Emyria; Neurotech; Bod Science; Elixinol; Creso Pharma; MGC Pharma by Steve Jones and Martin Lane January 31, 2023February 2, 2023 Althea Althea has said it is “on the verge” of becoming cash flow positive as it […]
Ecofibre becomes second company to confirm disappointing sleep trial results by Steve Jones January 30, 2023March 13, 2023
‘If a herb farmer can’t get a medicinal cannabis licence, there’s a problem with the system’ by Steve Jones January 25, 2023January 30, 2023
Montu teases discounts to patients in refer-a-friend marketing scheme by Steve Jones January 25, 2023January 25, 2023
‘We’re not giving up,’ says new Cann Group CEO as researchers pore over clinical trial results by Steve Jones January 24, 2023March 13, 2023
Cann Group COO Shane Duncan quits after four ‘challenging and exciting years’ by Steve Jones January 23, 2023January 23, 2023
Sleepless nights ahead for Cann Group as over-the-counter CBD trial fails the placebo challenge by Steve Jones January 19, 2023January 19, 2023
Medical Board of Australia set to crack down on online consultations by Martin Lane January 5, 2023January 12, 2023
MCIA puts industry revenue for H2 FY22 at more than A$100m by Martin Lane December 21, 2022December 22, 2022
